The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

Autor: Suvanjaa Sivalingam, Emil List Larsen, Daniel H. van Raalte, Marcel H. A. Muskiet, Mark M. Smits, Lennart Tonneijck, Jaap A. Joles, Bernt Johan von Scholten, Emilie Hein Zobel, Frederik Persson, Trine Henriksen, Lars Jorge Diaz, Tine W. Hansen, Henrik Enghusen Poulsen, Peter Rossing

Publikováno v: Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)

Abstract Glucagon-like peptide 1 receptor agonists have shown cardioprotective effects which have been suggested to be mediated through inhibition of oxidative stress. We investigated the effect of treatment with a glucagon-like peptide 1 receptor ag

Externí odkaz: https://doaj.org/article/3bcc699d77684b339336dcb21eb97295

Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes

Autor: Anne C. Hesp, Mark M. Smits, Erik J.M. van Bommel, Marcel H.A. Muskiet, Lennart Tonneijck, Max Nieuwdorp, Mark H.H. Kramer, Jaap A. Joles, Petter Bjornstad, Daniël H. van Raalte

Publikováno v: Journal of Diabetes and its Complications, 36(3):108127. Elsevier Inc.
Hesp, A C, Smits, M M, van Bommel, E J M, Muskiet, M H A, Tonneijck, L, Nieuwdorp, M, Kramer, M H H, Joles, J A, Bjornstad, P & van Raalte, D H 2022, ' Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes : Analysis of three clinical trials ', Journal of Diabetes and its Complications, vol. 36, no. 3, 108127 . https://doi.org/10.1016/j.jdiacomp.2022.108127
Journal of diabetes and its complications, 36(3):108127. Elsevier Inc.

Aims: Glomerular hyperfiltration plays a key role in the pathophysiology of diabetic kidney disease (DKD). Mechanisms underlying this adverse hemodynamic profile are incompletely understood. We hypothesized that systemic vascular pathology, including

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37bd6c59ff9f1357538deb8dbd2b67f0
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85123185465&origin=inward

The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

Autor: Emil List Larsen, Frank Geurts, Max Nieuwdorp, Marcel H.A. Muskiet, Daan J Touw, Henrik E. Poulsen, A.H. Jan Danser, Ewout J. Hoorn, Anna L. Emanuel, Daniël H. van Raalte, Erik J.M. van Bommel, Jaap A. Joles, Andrea Bozovic, Michaël J.B. van Baar, Mark M. Smits, Lennart Tonneijck, Mark H.H. Kramer

Publikováno v: Kidney International, 97(1), 202-212. ELSEVIER SCIENCE INC
Kidney international, 97(1), 202-212. Nature Publishing Group
Kidney International, 97(1), 202-212. Elsevier Inc.
van Bommel, E J M, Muskiet, M H A, van Baar, M J B, Tonneijck, L, Smits, M M, Emanuel, A L, Bozovic, A, Danser, A H J, Geurts, F, Hoorn, E J, Touw, D J, Larsen, E L, Poulsen, H E, Kramer, M H H, Nieuwdorp, M, Joles, J A & van Raalte, D H 2020, ' The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial ', Kidney International, vol. 97, no. 1, pp. 202-212 . https://doi.org/10.1016/j.kint.2019.09.013
Kidney International, 97(1), 202-212. Nature Publishing Group

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve hard renal outcomes in type 2 diabetes. This is possibly explained by the fact that SGLT2i normalize the measured glomerular filtration rate (mGFR) by increasing renal vascular resistance, as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ade058080ace5fb4db4e6592316e47fa
https://doi.org/10.1016/j.kint.2019.09.013

High Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients

Autor: Mark M. Smits, Daniël H. van Raalte, Lennart Tonneijck, Marco J. Bruno, Marcel H.A. Muskiet, Nanda C. Krak, Indra C Pieters, Djuna L. Cahen, Rosa M Bent, Kasper A. Overbeek, Karuna E W Vendrik

Publikováno v: Pancreas, 49(1), E5-E7. Lippincott Williams & Wilkins
Pancreas, 49(1), E5-E7. Lippincott Williams and Wilkins
Overbeek, K A, Krak, N C, Pieters, I C, Smits, M M, Bent, R M, Vendrik, K E W, Tonneijck, L, Muskiet, M H A, Van Raalte, D H, Bruno, M J & Cahen, D L 2020, ' High Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients ', Pancreas, vol. 49, no. 1, pp. E5-E7 . https://doi.org/10.1097/MPA.0000000000001444
Pancreas, 49(1), e5-e7. Lippincott Williams and Wilkins

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b3b65c706ffb46974abae578bfd366
https://pure.eur.nl/en/publications/73a327a7-f185-40f1-8a2c-cd500d51c11c

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

Autor: Mark M. Smits, Emil List Larsen, Emilie H. Zobel, Daniël H. van Raalte, Bernt Johan von Scholten, Lennart Tonneijck, Suvanjaa Sivalingam, Tine W. Hansen, Marcel H. A. Muskiet, Jaap A. Joles, Frederik Persson, Lars Jorge Diaz, Henrik E. Poulsen, Trine Henriksen, Peter Rossing

Publikováno v: Scientific Reports
Scientific Reports, 11(1):10624. Nature Publishing Group
Sivalingam, S, Larsen, E L, van Raalte, D H, Muskiet, M H A, Smits, M M, Tonneijck, L, Joles, J A, von Scholten, B J, Zobel, E H, Persson, F, Henriksen, T, Diaz, L J, Hansen, T W, Poulsen, H E & Rossing, P 2021, ' The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes ', Scientific Reports, vol. 11, no. 1, 10624 . https://doi.org/10.1038/s41598-021-90191-w
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)

Glucagon-like peptide 1 receptor agonists have shown cardioprotective effects which have been suggested to be mediated through inhibition of oxidative stress. We investigated the effect of treatment with a glucagon-like peptide 1 receptor agonist (li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a754cc228dea7ca5adfeaed315e3ef
http://europepmc.org/articles/PMC8134438